Chengbin Wu

Chengbin Wu is the founder of EpimAb Biotherapeutics. EpimAb Biotherapeutics has raised $219M in total funding. Latest round: Series C. Based in China.

About Chengbin Wu

Chengbin Wu is the CEO of EpimAb Biotherapeutics, a clinical-stage biotech company based in China specializing in bispecific antibody development. He has led the company through multiple funding rounds and advanced programs such as EMB-07 and EMB-01 toward clinical approval.

Chengbin Wu at a glance

More founders in China (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library